Kronos Bio Management
Management criteria checks 1/4
Kronos Bio's CEO is Norbert Bischofberger, appointed in Aug 2018, has a tenure of 5.75 years. total yearly compensation is $2.80M, comprised of 20.7% salary and 79.3% bonuses, including company stock and options. directly owns 13.71% of the company’s shares, worth $8.48M. The average tenure of the management team and the board of directors is 1.7 years and 4.9 years respectively.
Key information
Norbert Bischofberger
Chief executive officer
US$2.8m
Total compensation
| CEO salary percentage | 20.7% |
| CEO tenure | 5.8yrs |
| CEO ownership | 13.7% |
| Management average tenure | 1.7yrs |
| Board average tenure | 4.9yrs |
Recent management updates
Recent updates
Is Kronos Bio (NASDAQ:KRON) In A Good Position To Invest In Growth?
Jan 19
We're Keeping An Eye On Kronos Bio's (NASDAQ:KRON) Cash Burn Rate
Aug 21We Think Kronos Bio (NASDAQ:KRON) Needs To Drive Business Growth Carefully
Feb 22Is Kronos Bio (NASDAQ:KRON) In A Good Position To Deliver On Growth Plans?
Nov 01Kronos Bio, Invivoscribe to develop companion diagnostic for leukemia drug entospletinib
Aug 16Is Kronos Bio (NASDAQ:KRON) In A Good Position To Invest In Growth?
Jul 07We're Hopeful That Kronos Bio (NASDAQ:KRON) Will Use Its Cash Wisely
Feb 01How Much Of Kronos Bio, Inc. (NASDAQ:KRON) Do Insiders Own?
Mar 03Read This Before Selling Kronos Bio, Inc. (NASDAQ:KRON) Shares
Jan 09
Kronos Bio EPS misses by $4.10
Nov 18CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$113m |
| Sep 30 2023 | n/a | n/a | -US$119m |
| Jun 30 2023 | n/a | n/a | -US$120m |
| Mar 31 2023 | n/a | n/a | -US$123m |
| Dec 31 2022 | US$3m | US$580k | -US$133m |
| Sep 30 2022 | n/a | n/a | -US$164m |
| Jun 30 2022 | n/a | n/a | -US$165m |
| Mar 31 2022 | n/a | n/a | -US$161m |
| Dec 31 2021 | US$645k | US$320k | -US$151m |
| Sep 30 2021 | n/a | n/a | -US$122m |
| Jun 30 2021 | n/a | n/a | -US$128m |
| Mar 31 2021 | n/a | n/a | -US$108m |
| Dec 31 2020 | US$15m | US$399k | -US$88m |
| Sep 30 2020 | n/a | n/a | -US$61m |
| Jun 30 2020 | n/a | n/a | -US$25m |
| Mar 31 2020 | n/a | n/a | -US$20m |
| Dec 31 2019 | US$280k | US$200k | -US$16m |
Compensation vs Market: Norbert's total compensation ($USD2.80M) is above average for companies of similar size in the US market ($USD674.55K).
Compensation vs Earnings: Norbert's compensation has increased whilst the company is unprofitable.
CEO
Norbert Bischofberger (67 yo)
5.8yrs
Tenure
US$2,796,660
Compensation
Dr. Norbert W. Bischofberger, Ph D., has been an Independent Director of Morphic Holding, Inc. since June 14, 2019. Dr. Bischofberger serves as a Director of Kronos Bio, Inc. since April 2018.He joined Kr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 5.8yrs | US$2.80m | 13.71% $ 8.5m | |
| Co-Founder & Director | no data | US$118.45k | 0.61% $ 377.5k | |
| Secretary & Director | no data | US$118.45k | 1.52% $ 941.2k | |
| Interim CFO & Principal Accounting Officer | less than a year | no data | no data | |
| Vice President of Corporate Development & Investor Relations | 3yrs | no data | no data | |
| Senior Vice President of Corporate Operations & Legal | less than a year | no data | 0.34% $ 210.6k | |
| Senior Vice President of Research & Development | 3.3yrs | no data | 0.39% $ 241.6k | |
| Senior Vice President of Clinical Development | 2.3yrs | no data | 0.32% $ 199.1k | |
| Senior Vice President of Drug Discovery & Pharmaceutical Development | 1.1yrs | no data | no data | |
| Senior Vice President of Corporate Strategy & Portfolio Management | less than a year | no data | no data |
1.7yrs
Average Tenure
52yo
Average Age
Experienced Management: KRON's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.1yrs | US$2.80m | 13.71% $ 8.5m | |
| Co-Founder & Director | 6.9yrs | US$118.45k | 0.61% $ 377.5k | |
| Secretary & Director | 6.9yrs | US$118.45k | 1.52% $ 941.2k | |
| Scientific Advisory Board Chairman | no data | no data | no data | |
| Independent Chairman of the Board | 6.5yrs | US$158.45k | 1.13% $ 700.0k | |
| Independent Director | 3.7yrs | US$133.45k | 0.023% $ 14.4k | |
| Independent Director | 3.2yrs | US$88.49k | 0.019% $ 11.7k | |
| Independent Director | 2.5yrs | US$123.45k | 0% $ 0 | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Independent Director | 1.2yrs | no data | no data |
4.9yrs
Average Tenure
52yo
Average Age
Experienced Board: KRON's board of directors are considered experienced (4.9 years average tenure).